Literature DB >> 6871823

Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas.

D E Dosoretz, L L Gunderson, S Hedberg, B Hoskins, P H Blitzer, W Shipley, A Cohen.   

Abstract

The records of 25 patients with unresectable carcinoma of the rectum and rectosigmoid who received preoperative radiation therapy (RT) were reviewed. Twenty patients were considered to be resectable following RT (80%). Sixteen patients (64%) underwent curative resections. All patients with unresectable tumors following RT died with tumor within two and one half years (median survival, 11 months). For patients undergoing curative resection, the probability of two- and five-year survival was 56% and 43%, respectively. In this latter group, five of seven patients with treatment failures (71%) had a pelvic component of disease. The incidence of pelvic recurrence was correlated with the pathologic stage, extent of resection and preoperative radiation dose. The need for more aggressive treatment for patients with these advanced tumors is emphasized. Future treatment alternatives are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6871823     DOI: 10.1002/1097-0142(19830901)52:5<814::aid-cncr2820520511>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  The role of intra-operative irradiation in locally advanced primary and recurrent rectal adenocarcinoma.

Authors:  L L Gunderson; M J O'Connell; R R Dozois
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

2.  Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.

Authors:  Stephanie Terezakis; Lisa Morikawa; Abraham Wu; Zhigang Zhang; Weiji Shi; Martin R Weiser; Philip B Paty; Jose Guillem; Larissa Temple; Garrett M Nash; Michael J Zelefsky; Karyn A Goodman
Journal:  Ann Surg Oncol       Date:  2015-01-29       Impact factor: 5.344

3.  Intraoperative and external beam irradiation for locally advanced colorectal cancer.

Authors:  L L Gunderson; J K Martin; R W Bèart; D M Nagorney; J M Fieck; H S Wieand; A Martinez; M J O'Connell; J A Martenson; D C McIlrath
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

4.  Adjuvant treatment in colorectal cancer: an update.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

5.  The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer.

Authors:  B M Nakfoor; C G Willett; P C Shellito; D S Kaufman; W J Daly
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

Review 6.  Radiation treatment for rectal cancer.

Authors:  B J Cummings
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

7.  Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.

Authors:  G Frykholm; B Glimelius; S Richter; J Carlsson
Journal:  In Vitro Cell Dev Biol       Date:  1991-12

8.  Initially unresectable rectal adenocarcinoma treated with preoperative irradiation and surgery.

Authors:  W M Mendenhall; R R Million; K I Bland; W W Pfaff; E M Copeland
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

Review 9.  Pre-operative and post-operative radiotherapy and rectal cancer.

Authors:  L Påhlman; B Glimelius
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

10.  Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma.

Authors:  A M Lowy; T A Rich; J M Skibber; R A Dubrow; S A Curley
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.